MCHR1 in Both Dopaminergic Neurons and Astrocytes in the SNpc Contributes to Acupuncture's Anti-Parkinsonian Effects
Abstract
Acupuncture stimulation at the GB34 acupoint has been reported to alleviate motor dysfunction in Parkinson's disease (PD) by activating the lateral hypothalamic melanin concentrating hormone (MCH) neurons projecting to the substantia nigra pars compacta (SNpc). MCH receptor 1 (MCHR1) signaling is also known to be essential for the anti-Parkinsonian effects of acupuncture. However, the cellular distribution of MCHR1 and its cell type-specific contributions to the therapeutic effects of acupuncture in PD remain largely unexplored. Here, we show that MCHR1 is expressed in both dopaminergic neurons and astrocytes within the SNpc, with higher expression in dopaminergic neurons. We further demonstrate that cell-type-specific gene-silencing of MCHR1 in either dopaminergic neurons or astrocytes significantly blocks acupuncture-induced motor recovery and dopaminergic neuron protection. These findings indicate that both neuronal and astrocytic MCHR1 contribute to the anti-Parkinsonian effects of acupuncture. Together, this study provides new insight into MCHR1 as a potential therapeutic target for PD.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.